Larson Financial Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16 | Hold |
8
| – | – | ﹤0.01% | 3228 |
|
|
2025
Q1 | $13 | Sell |
8
-83
| -91% | -$135 | ﹤0.01% | 3027 |
|
|
2024
Q4 | $167 | Hold |
91
| – | – | ﹤0.01% | 2480 |
|
|
2024
Q3 | $526 | Buy |
91
+83
| +1,038% | +$480 | ﹤0.01% | 2098 |
|
|
2024
Q2 | $65 | Hold |
8
| – | – | ﹤0.01% | 2318 |
|
|
2024
Q1 | $111 | Hold |
8
| – | – | ﹤0.01% | 1687 |
|
|
2023
Q4 | $51 | Hold |
8
| – | – | ﹤0.01% | 1755 |
|
|
2023
Q3 | $39 | Hold |
8
| – | – | ﹤0.01% | 1681 |
|
|
2023
Q2 | $45 | Hold |
8
| – | – | ﹤0.01% | 1541 |
|
|
2023
Q1 | $82 | Hold |
8
| – | – | ﹤0.01% | 1502 |
|
|
2022
Q4 | $156 | Hold |
8
| – | – | ﹤0.01% | 1436 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 1343 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 1235 |
|
|
2022
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 1099 |
|
|
2021
Q4 | $0 | Buy |
+8
| New | – | ﹤0.01% | 1116 |
|
|
2020
Q2 | – | Sell |
-6
| Closed | -$1K | – | 710 |
|
|
2020
Q1 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 485 |
|